A B S T R A C T In vivo androgen kinetics were determined in six young (21-49 yr) and elderly men (62-77 yr) with prostate hyperplasia (BPH). Steadystate infusions of [14C]testosterone and [3H]androstanediol (3adiol) were given, which allowed determination of the conversions testosterone -* dihydrotesterone (DHT) ti 3adiol. These infusions also yield metabolic clearance data which, together with measurement of nonisotopic steroid levels, yield estimations of blood production rates. The production rate for testosterone was 6.04±+1.66 vs. 3.69+±0.62 mg/d, whereas the production rate for 3adiol was 319±57 and 193+34 ,tg/d (P < 0.05 both groups). The irreversible conversion rate of testosterone to DHT was 3.1+0.4 and 3.5±0.9% (NS). The back conversion of 3adiol to DHT was high (68+25 vs. 81±+17, NS) indicating that 3adiol might cause BPH as a result of conversion to DHT in vivo. The conversion of DHT to 3adiol is reduced in the elderly group (15.8±2.6 and 6.3+1.4, P < 0.001). Since DHT formation in the prostate is a key event in development of BPH and blood DHT appears to be a measure of extrasplanchnic sexual target tissue activity, our in vivo studies suggest that the tissue increase in DHT may result from reduced metabolism and the activity of 3a-oxidoreduction favors the oxidative pathway in elderly men.